Recombinant Chromobacterium violaceum Thiazole synthase (thiG)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can be used as a reference.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
thiG; CV_3766; Thiazole synthase; EC 2.8.1.10
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-264
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Chromobacterium violaceum (strain ATCC 12472 / DSM 30191 / JCM 1249 / NBRC 12614 / NCIMB 9131 / NCTC 9757)
Target Names
thiG
Target Protein Sequence
MDDKLVIAGR EYGSRLLVGT GKYKDFEQTA AALDVSGTEI VTAAIRRVNL GQNANEPNLL DFLPKNRYNL LPNTAGCYSA EDAIRTLRLA RELLDDHRFV KLEVLGDPNN LYPNVRETLK AAEVLVAEGF DVLVYTSDDP IVARELEQIG CCAIMPLASL IGSGMGILNP WNLQLIIEQS KVPVIVDAGV GTASDAAIAM ELGCDGVLMN TAIAAARDPV RMAHAMKLAV EAGRAAYLAG RMPKRFYSAV PSSPSEGVIS SVKS
Uniprot No.

Target Background

Function
This enzyme catalyzes the rearrangement of 1-deoxy-D-xylulose 5-phosphate (DXP) to produce the thiazole phosphate moiety of thiamine. The sulfur is supplied by the thiocarboxylate moiety of the carrier protein ThiS. In vitro, hydrogen sulfide (H₂S) can serve as an alternative sulfur source.
Database Links

KEGG: cvi:CV_3766

STRING: 243365.CV_3766

Protein Families
ThiG family
Subcellular Location
Cytoplasm.

Q&A

What is the genomic context of thiG in Chromobacterium violaceum?

Chromobacterium violaceum has a genome with notably high GC content (64.83%), which presents specific challenges for gene amplification and cloning . While the search results don't specifically address the thiG gene's genomic context, the violacein biosynthetic gene cluster in C. violaceum spans approximately 7.3 kilobase pairs . For researchers working with thiG, it's important to consider the high GC content when designing primers and optimizing PCR conditions. Employing PCR additives such as DMSO (5-10%), betaine (1-2M), or specialized polymerases designed for GC-rich templates is recommended to overcome amplification difficulties associated with secondary structures and increased melting temperatures.

How does bacterial thiazole synthase differ from eukaryotic thiazole synthase?

Bacterial thiazole synthase (thiG) functions mechanistically differently from eukaryotic thiazole synthase. In eukaryotes like Saccharomyces cerevisiae, thiazole synthase (encoded by THI4) utilizes NAD as a precursor, which is first converted to ADP-ribose followed by a series of transformations to form the thiazole moiety . The eukaryotic pathway involves the intermediate formation of ADP-ribulose and employs a single enzyme for multiple reaction steps . In contrast, bacterial thiG typically works in conjunction with other proteins including ThiS, ThiF, and ThiO or ThiH in a complex pathway utilizing different precursors. These fundamental differences make C. violaceum thiG an interesting target for comparative enzymology studies and highlight the evolutionary divergence in essential metabolic pathways.

What are the expected properties of recombinant thiG from C. violaceum?

Based on general properties of C. violaceum proteins, recombinant thiG is likely to exhibit characteristics influenced by the organism's high GC content genome. When designing expression systems, researchers should consider codon optimization for the host organism, as the high GC content of C. violaceum may create codon usage bias incompatible with common expression hosts such as E. coli . The protein may require specific chaperones for proper folding, and expression conditions might need optimization regarding temperature, induction time, and media composition. While specific properties of C. violaceum thiG aren't detailed in the search results, researchers should be aware that Chromobacterium proteins often require specialized conditions for optimal expression and activity.

What are the optimal expression systems for recombinant C. violaceum thiG?

Based on successful heterologous expression strategies for other C. violaceum proteins, E. coli expression systems utilizing T7 promoter-based vectors like pET3a and pET11b represent a logical starting point for thiG expression . When working with potentially challenging GC-rich genes from C. violaceum, consider these methodological approaches:

  • Strain selection: BL21(DE3) derivatives with additional chaperones (e.g., BL21-CodonPlus, Rosetta strains) can address codon bias issues

  • Expression conditions: Lower temperatures (16-20°C) and reduced inducer concentrations often improve soluble protein yield

  • Media optimization: Enriched media such as Terrific Broth or auto-induction media can increase protein yield

  • Co-expression strategies: If thiG functions in a complex with other proteins, co-expression may improve solubility and activity

The expression of the violacein biosynthetic cluster from C. violaceum in E. coli required careful optimization of carbon sources, culture media, inducer concentrations, and even precursor supplementation, suggesting similar considerations may benefit thiG expression .

How can I troubleshoot low expression levels of recombinant C. violaceum thiG?

When encountering low expression levels of recombinant C. violaceum thiG, implement a systematic troubleshooting approach:

  • Gene sequence verification: Confirm the sequence integrity with particular attention to the high GC content regions that may have been prone to errors during cloning

  • Expression vector design: Consider altering the fusion tag position (N- or C-terminal) and type (His, GST, MBP, SUMO)

  • Growth parameters: Systematically test various temperatures (37°C, 30°C, 25°C, 18°C), IPTG concentrations (0.1-1.0 mM), and induction timing

  • Cell lysis optimization: Employ different lysis methods (sonication, pressure-based, chemical) to ensure efficient protein extraction

  • Solubility enhancement: Include stabilizing additives in the lysis buffer (glycerol, reducing agents, specific ions)

For C. violaceum proteins, special consideration should be given to the high GC content which can form secondary structures in mRNA that inhibit translation. In such cases, specific translation enhancing elements or synthetic gene designs with optimized codon usage while maintaining the same amino acid sequence may significantly improve expression levels .

What purification strategies are most effective for recombinant thiG from C. violaceum?

Though the search results don't provide specific information on thiG purification, effective purification strategies can be designed based on general principles and knowledge of other recombinant proteins:

Purification StepMethodBuffer ConsiderationsSpecial Notes for C. violaceum thiG
Initial CaptureIMAC (for His-tagged)50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerolInclude reducing agent to prevent oxidation
IntermediateIon Exchange20 mM MES/HEPES at optimum pHDetermine optimal pH based on thiG pI prediction
PolishingSize ExclusionPBS or Tris buffer with stabilizersAssess oligomeric state
AlternativeAffinity ChromatographySubstrate/cofactor-basedConsider potential thiazole precursor affinity

When designing a purification protocol, it's critical to include activity assays at each step to monitor protein functionality, especially since thiG may require specific cofactors or metal ions for stability and activity. Based on the challenges reported with other C. violaceum proteins, including stabilizers like glycerol (10-20%) and reducing agents in all buffers is recommended to prevent aggregation and maintain enzyme activity .

What assays can be used to confirm the enzymatic activity of recombinant C. violaceum thiG?

To confirm the enzymatic activity of recombinant thiG from C. violaceum, researchers can employ several complementary approaches:

  • Direct product detection: HPLC or LC-MS analysis to detect the formation of the thiazole moiety from precursors

  • Coupled enzyme assays: Measuring the activity in conjunction with other enzymes in the thiamine biosynthesis pathway

  • Complementation studies: Testing the ability of C. violaceum thiG to rescue thiG-deficient bacterial strains

For detailed mechanistic studies, researchers can use approaches similar to those employed for S. cerevisiae thiazole synthase, where various intermediates were identified through LC-MS analysis . When the unstable intermediates are formed, they can be trapped using specific chemical agents; for example, ortho-phenylenediamine (oPDA) was successfully used to trap unstable intermediates in the eukaryotic thiazole synthesis pathway .

A robust activity assay would involve incubating purified thiG with its substrate(s) under optimized conditions (pH, temperature, cofactors), followed by analysis of reaction products using chromatographic techniques coupled with mass spectrometry.

What structural features are important for C. violaceum thiG function?

While the specific structural features of C. violaceum thiG are not detailed in the search results, insights can be drawn from studies of bacterial thiazole synthases more broadly:

  • Active site architecture: Bacterial thiG proteins typically contain conserved catalytic residues involved in substrate binding and catalysis. Site-directed mutagenesis studies targeting these residues (based on sequence homology with well-characterized thiG proteins) can identify essential amino acids.

  • Protein-protein interaction domains: Bacterial thiazole biosynthesis often involves multi-protein complexes. Identifying domains responsible for interactions with other thiamine biosynthesis proteins (e.g., ThiS, ThiF) would be crucial for understanding the complete functional mechanism.

  • Metal binding sites: Many thiazole synthases require metal cofactors for activity. Spectroscopic methods (e.g., ICP-MS) can identify associated metals, while mutations of potential metal-coordinating residues can confirm their importance.

Researchers can employ protein crystallography, cryo-EM, or computational modeling approaches to elucidate the detailed structure of C. violaceum thiG and correlate structural elements with enzymatic function through mutational analyses.

How does thiG interact with other proteins in the thiamine biosynthesis pathway?

In bacterial systems, thiG typically functions in a complex interplay with several other proteins in the thiamine biosynthesis pathway. While C. violaceum-specific interactions aren't detailed in the search results, researchers investigating these interactions should consider:

  • Pull-down assays: Using tagged recombinant thiG to identify interacting partners from C. violaceum lysates

  • Bacterial two-hybrid systems: To systematically test interactions with known thiamine biosynthesis proteins

  • Co-expression and co-purification experiments: To determine stable complex formation

  • Surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC): For quantitative measurement of binding affinities

Drawing parallels to studies of other bacterial thiazole synthases, researchers should investigate interactions with ThiS (the sulfur carrier protein), ThiF (adenylation enzyme), and either ThiO or ThiH (depending on whether C. violaceum uses the oxidative or fermentative pathway for thiazole formation). Co-immunoprecipitation techniques, similar to those successfully used to demonstrate protein-protein interactions in C. violaceum , could provide valuable insights into the thiamine biosynthesis protein interaction network.

How does C. violaceum thiG differ from thiG in other bacterial species?

Comparison of thiG across bacterial species can reveal important evolutionary and functional insights. For a comprehensive comparative analysis, researchers should:

  • Perform phylogenetic analysis of thiG sequences across bacterial phyla, with particular focus on other Betaproteobacteria (the class to which C. violaceum belongs)

  • Analyze sequence conservation patterns to identify uniquely conserved residues in C. violaceum thiG

  • Compare gene neighborhood and operon organization, as thiamine biosynthesis genes are often clustered in bacterial genomes

  • Investigate differences in substrate specificity and catalytic efficiency through comparative enzymology

While specific differences of C. violaceum thiG aren't addressed in the search results, researchers should note that C. violaceum has unique metabolic capabilities, including violacein production, which may influence its thiamine metabolism requirements . The high GC content of the C. violaceum genome may also have imposed selective pressure resulting in distinctive features of its thiG protein .

How can I use computational approaches to predict functional aspects of C. violaceum thiG?

Computational approaches provide valuable insights for guiding experimental work on C. violaceum thiG:

  • Homology modeling: Generate structural models based on crystal structures of thiG from other organisms

  • Molecular docking: Predict substrate binding modes and identify key interaction residues

  • Molecular dynamics simulations: Analyze protein flexibility and conformational changes during catalysis

  • Sequence-based predictions: Identify conserved domains, potential post-translational modifications, and subcellular localization signals

For C. violaceum specifically, researchers should account for the high GC content genome when using computational approaches. This characteristic may influence codon usage patterns and subsequently protein structure prediction accuracy . Integrating results from multiple prediction algorithms and validation through focused experimental approaches (e.g., site-directed mutagenesis of predicted catalytic residues) is recommended for robust computational analyses.

What can we learn from comparing bacterial and eukaryotic thiazole biosynthesis pathways?

Comparative analysis of bacterial (thiG-dependent) and eukaryotic (THI4-dependent) thiazole biosynthesis pathways reveals fundamental differences in substrate utilization and catalytic mechanisms:

  • Substrate diversity: Eukaryotic THI4 utilizes NAD as a substrate, converting it through ADP-ribose and ADP-ribulose intermediates , while bacterial thiG typically uses different precursors.

  • Catalytic mechanisms: Eukaryotic THI4 has been characterized as a "suicide enzyme" that uses a conserved cysteine residue as a sulfur donor, becoming inactive after a single reaction cycle. In contrast, bacterial thiG obtains sulfur from the ThiS sulfur carrier protein, allowing for multiple catalytic cycles.

  • Evolutionary implications: The distinct mechanisms suggest independent evolutionary origins of thiazole biosynthesis in bacteria and eukaryotes, representing a case of convergent evolution for thiamine production.

These comparisons can inform both fundamental understanding of metabolic evolution and potential applications in metabolic engineering or drug development. The research strategies employed for characterizing the eukaryotic pathway, such as the use of chemical trapping agents for unstable intermediates and mutation of active site residues, provide valuable methodological approaches that can be applied to studies of C. violaceum thiG .

How can C. violaceum thiG be used for metabolic engineering applications?

Thiazole synthase plays a crucial role in thiamine biosynthesis, an essential cofactor for many metabolic enzymes. Potential metabolic engineering applications include:

  • Enhancing thiamine production: Overexpression of optimized C. violaceum thiG in industrial microorganisms could increase thiamine yields

  • Pathway reconstruction: Integration of C. violaceum thiG into organisms lacking endogenous thiamine biosynthesis pathways

  • Creation of thiamine-dependent biosensors: Using thiG in synthetic biology circuits to monitor metabolic states

  • Enzyme engineering: Modification of thiG substrate specificity to generate novel thiazole derivatives with potential bioactive properties

When developing such applications, researchers should consider the successful methodology demonstrated for the heterologous expression of the violacein biosynthetic pathway from C. violaceum, which required optimization of expression vectors, media composition, and induction parameters . Similar strategies would likely benefit thiG-based metabolic engineering projects.

What approaches can be used to study the role of thiG in C. violaceum pathogenicity?

Though thiG's specific role in C. violaceum pathogenicity is not directly addressed in the search results, researchers interested in this aspect could employ several approaches:

  • Gene knockout studies: Generate thiG deletion mutants and assess virulence in appropriate infection models (considering C. violaceum can cause infections with high fatality rates)

  • Conditional expression systems: Create strains with regulated thiG expression to study the impact of thiamine availability on virulence factor production

  • Transcriptomic and proteomic analyses: Compare gene/protein expression patterns between wild-type and thiG-mutant strains under infection-relevant conditions

  • Metabolomic profiling: Analyze changes in thiamine-dependent metabolic pathways during infection

C. violaceum pathogenicity involves multiple virulence factors, including type III secretion systems (T3SS) encoded by pathogenicity islands and the production of violacein pigment . Investigating potential links between thiamine metabolism (dependent on thiG) and these known virulence mechanisms could provide novel insights into bacterial pathophysiology.

How can I design inhibitors targeting C. violaceum thiG for antimicrobial development?

Design of specific inhibitors targeting C. violaceum thiG requires a rational, structure-based approach:

  • Structural determination: Obtain high-resolution crystal structures of C. violaceum thiG, preferably in complex with substrates or substrate analogs

  • Identification of druggable pockets: Computational analysis to identify binding sites suitable for small molecule inhibitors

  • Virtual screening: In silico screening of compound libraries against identified binding sites

  • Fragment-based drug discovery: Identification of weakly binding fragments that can be elaborated into potent inhibitors

  • Structure-activity relationship studies: Systematic modification of hit compounds to optimize potency and selectivity

For antimicrobial development targeting C. violaceum specifically, researchers should consider the organism's intrinsic resistance to multiple antibiotics. The violacein pigment produced by C. violaceum has been associated with resistance to various antibiotics including vancomycin, ampicillin, and linezolid . Therefore, thiG inhibitors would ideally be designed to bypass common resistance mechanisms while maintaining selectivity to minimize effects on host thiamine metabolism.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.